• 1
    Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2008. National Cancer Institute: Bethesda, MD. Based on November 2010 SEER data submission, posted to the SEER Web site, 2011.
  • 2
    Curtis RE, Freedman DM, Ron E, et al, eds. New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. NIH Publication 05-5302. National Cancer Institute, Bethesda, MD; 2006.
  • 3
    Nagarajan R, Kamruzzaman A, Ness KK, et al. Twenty years of follow-up of survivors of childhood osteosarcoma: a report from the Childhood Cancer Survivor Study. Cancer. 2011;117:625-634.
  • 4
    Ginsberg JP, Goodman P, Leisenring W, et al. Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study. J Natl Cancer Inst. 2010;102:1272-1283.
  • 5
    Waguespack S, Wells S, Ross J, Bleyer A. Thyroid cancer. In: Bleyer A, O'Leary M, Barr R, Ries LAG, eds. SEER AYA Monograph. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. NIH Publication 06-5767. Bethesda, MD: National Cancer Institute, NIH; 2006:143-154.
  • 6
    Ng AK, Travis LB. Subsequent malignant neoplasms in cancer survivors. Cancer J. 2008;14:429-434.
  • 7
    Oeffinger KC, Tonorezos ES. The cancer is over, now what?: Understanding risk, changing outcomes. Cancer. 2011;117:2250-2257.
  • 8
    Coccia PF, Altman J, Bhatia S, et al. Adolescent and young adult oncology. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2012;10:1112-1150.
  • 9
    Lerro CC, Robbins AS, Phillips JL, Stewart AK. Comparison of Cases Captured in the National Cancer Data Base with Those in Population-based Central Cancer Registries. Ann Surg Oncol. 2013;20:1759-1765.
  • 10
    Raval MV, Bilimoria KY, Stewart AK, Bentrem DJ, Ko CY. Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol. 2009;99:488-490.
  • 11
    Phillips JK, Stewart AK, eds. Facility Oncology Registry Data Standards. Chicago, IL: Commission on Cancer; 2011.
  • 12
    Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities. Washington, DC: National Academies Press; 2003.
  • 13
    Vriens MR, Moses W, Weng J, et al. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer. 2011;117:259-267.
  • 14
    Yu GP, Li JC, Branovan D, McCormick S, Schantz SP. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid. 2010;20:465-473.
  • 15
    Stroup AM, Harrell CJ, Herget KA. Long-term survival in young women: hazards and competing risks after thyroid cancer. J Cancer Epidemiol. 2012;2012:641372.
  • 16
    Children's Oncology Group.Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Accessed January 10, 2013.
  • 17
    Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22:4979-4990.
  • 18
    Jonklaas J, Nogueras-Gonzalez G, Munsell M, et al. The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab. 2012;97:E878-E887.
  • 19
    Kovalchik SA, Ronckers CM, Veiga LH, et al. Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J Clin Oncol. 2013;31:119-127.